Global Financial Private Client’s Regeneron Pharmaceuticals REGN Stock Holding History

Global Financial Private Client’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-61	Closed	-$38.7K	–	1280
2025 Q1	$38.7K	Buy	61 +2	+3%	+$1.38K	0.01%	365
2024 Q4	$42K	Sell	59 -6	-9%	-$5.04K	0.02%	336
2024 Q3	$68.3K	Buy	65 +21	+48%	+$23.4K	0.03%	297
2024 Q2	$46.2K	Hold	44	–	–	0.02%	306
2024 Q1	$42.6K	Hold	44	–	–	0.02%	320
2023 Q4	$38.6K	Hold	44	–	–	0.02%	320
2023 Q3	$36K	Hold	44	–	–	0.02%	315
2023 Q2	$31.6K	Hold	44	–	–	0.02%	331
2023 Q1	$36.4K	Hold	44	–	–	0.02%	314
2022 Q4	$31.7K	Hold	44	–	–	0.02%	319
2022 Q3	$32.3K	Hold	44	–	–	0.02%	309
2022 Q2	$26.2K	Hold	44	–	–	0.01%	322
2022 Q1	$30.6K	Hold	44	–	–	0.01%	316
2021 Q4	$27.8K	Hold	44	–	–	0.01%	314
2021 Q3	$25.1K	Hold	44	–	–	0.01%	294
2021 Q2	$25.3K	Hold	44	–	–	0.01%	299
2021 Q1	$20.9K	Hold	44	–	–	0.02%	274
2020 Q4	$21.3K	Hold	44	–	–	0.02%	261
2020 Q3	$25K	Hold	44	–	–	0.02%	241
2020 Q2	$26.8K	Sell	44 -31	-41%	-$17.6K	0.02%	271
2020 Q1	$37.2K	Buy	+75	New	+$30.9K	0.04%	240

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Global Financial Private Client's REGN Position: Q2 2025 in Review

Global Financial Private Client sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 61 shares — an estimated $38.7K sold.

Global Financial Private Client first reported a position in REGN in Q1 2020 and held it in 21 quarters. The position peaked at $68.3K in Q3 2024. 1,202 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

Global Financial Private Client reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Global Financial Private Client sold 61 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $38.7K.
Global Financial Private Client first reported a position in Regeneron Pharmaceuticals in Q1 2020 and held it in 21 quarters.
Global Financial Private Client's Regeneron Pharmaceuticals position peaked at $68.3K in Q3 2024.
1,202 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.